The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer
Publication
, Conference
Moul, JW; Wiederkehr, D; Connolly, M; Sendersky, V; Onel, E
Published in: Journal of Clinical Oncology
May 20, 2008
Duke Scholars
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
16002 / 16002
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Moul, J. W., Wiederkehr, D., Connolly, M., Sendersky, V., & Onel, E. (2008). The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. In Journal of Clinical Oncology (Vol. 26, pp. 16002–16002). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2008.26.15_suppl.16002
Moul, J. W., D. Wiederkehr, M. Connolly, V. Sendersky, and E. Onel. “The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer.” In Journal of Clinical Oncology, 26:16002–16002. American Society of Clinical Oncology (ASCO), 2008. https://doi.org/10.1200/jco.2008.26.15_suppl.16002.
Moul JW, Wiederkehr D, Connolly M, Sendersky V, Onel E. The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16002–16002.
Moul, J. W., et al. “The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer.” Journal of Clinical Oncology, vol. 26, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2008, pp. 16002–16002. Crossref, doi:10.1200/jco.2008.26.15_suppl.16002.
Moul JW, Wiederkehr D, Connolly M, Sendersky V, Onel E. The relationship between LHRH-agonist depot formulations and frequency of follow-up with health care providers in patients with prostate cancer. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2008. p. 16002–16002.
Published In
Journal of Clinical Oncology
DOI
EISSN
1527-7755
ISSN
0732-183X
Publication Date
May 20, 2008
Volume
26
Issue
15_suppl
Start / End Page
16002 / 16002
Publisher
American Society of Clinical Oncology (ASCO)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences